Analyst Rating Changes — Upgrades, Downgrades & Price Targets

52675 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Aug 13 00:18 UTC	BLTE Belite Bio	◎ Target	HC Wainwright	Yi Chen ★★☆☆☆ #2429	Buy	$200.00→ $214.00+7.0%
Aug 13 00:18 UTC	BKKT Bakkt	◎ Target	Benchmark	Mark Palmer ★★★★☆ #755	Buy	$19.00→ $12.00-36.8%
Aug 13 00:18 UTC	BHVN Biohaven	◎ Target	Morgan Stanley	Terence Flynn ★★★★☆ #866	Overweight	$18.00→ $19.00+5.6%
Aug 13 00:18 UTC	BHST BioHarvest Sciences	◎ Target	Roth Capital	Sean McGowan ★☆☆☆☆ #2954	Buy	$10.00→ $8.00-20.0%
Aug 13 00:18 UTC	BHST BioHarvest Sciences	◎ Target	Maxim Group	Anthony Vendetti ★☆☆☆☆ #3194	Buy	$12.00→ $5.00-58.3%
Aug 13 00:18 UTC	BGS B&G Foods	◎ Target	TD Cowen	Robert Moskow ★★★★☆ #500	Sell	$4.00→ $3.00-25.0%
Aug 13 00:18 UTC	BGEO Lion Finance Group	◎ Target	JPMorgan Chase & Co.	firm only	Overweight	£139→ £141+1.4%
Aug 13 00:18 UTC	BCSF Bain Capital Specialty Finance	◎ Target	Wells Fargo & Company	Finian O'Shea ★★★☆☆ #1688	Equal Weight	$13.00→ $12.00-7.7%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	Wedbush	David Nierengarten ★★★☆☆ #2127	Outperform	$30.00→ $33.00+10.0%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	Mizuho	Joseph Catanzaro ★★☆☆☆ #2485	Neutral	$18.00→ $20.00+11.1%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	The Goldman Sachs Group	Richard Law not yet tracked	Neutral	$18.00→ $20.00+11.1%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	Wells Fargo & Company	Eva Fortea Verdejo ★★★★☆ #820	Equal Weight	$16.00→ $23.00+43.8%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	BTIG Research	Jeet Mukherjee ★★★☆☆ #2206	Buy	$28.00→ $39.00+39.3%
Aug 13 00:18 UTC	BBOX Tritax Big Box REIT	◎ Target	JPMorgan Chase & Co.	firm only	Overweight	GBX 180→ GBX 190+5.6%
Aug 13 00:18 UTC	BBIO BridgeBio Pharma	◎ Target	Truist Financial	Danielle Brill ★★★☆☆ #2088	Buy	$102.00→ $107.00+4.9%
Aug 13 00:18 UTC	BBIO BridgeBio Pharma	◎ Target	JPMorgan Chase & Co.	Anupam Rama ★★☆☆☆ #2747	Overweight	$100.00→ $111.00+11.0%
Aug 13 00:18 UTC	BBIO BridgeBio Pharma	◎ Target	Canaccord Genuity Group	Whitney Ijem ★★☆☆☆ #2814	Buy	$104.00→ $106.00+1.9%
Aug 13 00:18 UTC	B Barrick Mining	◎ Target	Scotiabank	Tanya Jakusconek ★★☆☆☆ #2297	Sec→ r Outperform	$57.00→ $55.00-3.5%
Aug 13 00:18 UTC	AXSM Axsome Therapeutics	◎ Target	Mizuho	Graig Suvannavejh ★★☆☆☆ #2757	Outperform	$306.00→ $316.00+3.3%
Aug 13 00:18 UTC	AXP American Express	◎ Target	Piper Sandler	Bill Carcache not yet tracked	Overweight	$396.00→ $405.00+2.3%
Aug 13 00:18 UTC	ATI ATI	◎ Target	KeyCorp	Michael Leshock ★☆☆☆☆ #3060	Overweight	$211.00→ $258.00+22.3%
Aug 13 00:18 UTC	ARMK Aramark	◎ Target	Jefferies Financial Group	Stephanie Moore ★★☆☆☆ #2456	Buy	$62.00→ $70.00+12.9%
Aug 13 00:18 UTC	ARMK Aramark	◎ Target	Stifel Nicolaus	Shlomo Rosenbaum ★★★★★ #153	Buy	$54.00→ $70.00+29.6%
Aug 13 00:18 UTC	ARMK Aramark	◎ Target	UBS Group	Joshua Chan ★★★☆☆ #1530	Buy	$67.00→ $71.00+6.0%
Aug 13 00:18 UTC	ARMK Aramark	◎ Target	Robert W. Baird	Andrew Wittmann ★★★★☆ #416	Outperform	$63.00→ $69.00+9.5%
Aug 13 00:18 UTC	AR Antero Resources	◎ Target	Benchmark	Subash Chandra ★★☆☆☆ #2577	Buy	$44.00→ $47.00+6.8%
Aug 13 00:18 UTC	APP AppLovin	◎ Target	BTIG Research	Clark Lampen ★★☆☆☆ #2744	Buy	$574.00→ $408.00-28.9%
Aug 13 00:18 UTC	APC Anadarko Petroleum	◎ Target	UBS Group	Josh Silverstein ★★★☆☆ #1591	Buy	$22.00→ $21.00-4.5%
Aug 13 00:18 UTC	APA APA	◎ Target	Benchmark	Subash Chandra ★★☆☆☆ #2577	Buy	$40.00→ $46.00+15.0%
Aug 13 00:18 UTC	ANF Abercrombie & Fitch	◎ Target	UBS Group	Mauricio Serna ★★★★★ #290	Buy	$136.00→ $153.00+12.5%
Aug 13 00:18 UTC	ANF Abercrombie & Fitch	◎ Target	Jefferies Financial Group	Corey Tarlowe ★★★★☆ #623	Buy	$110.00→ $135.00+22.7%
Aug 13 00:18 UTC	AMTM Amentum	◎ Target	UBS Group	Gavin Parsons ★★★☆☆ #1665	Neutral	$23.00→ $24.00+4.3%
Aug 13 00:18 UTC	AMTM Amentum	◎ Target	BTIG Research	Andre Madrid ★★☆☆☆ #2667	Buy	$35.00→ $30.00-14.3%
Aug 13 00:18 UTC	AMTM Amentum	◎ Target	Royal Bank Of Canada	Ken Herbert not yet tracked	Sec→ r Perform	$28.00→ $26.00-7.1%
Aug 13 00:18 UTC	AMRZ Amrize	◎ Target	Stephens	Trey Grooms ★★★☆☆ #1935	Overweight	$65.00→ $54.00-16.9%
Aug 13 00:18 UTC	AMH American Homes 4 Rent	◎ Target	Morgan Stanley	Adam Kramer ★★★☆☆ #1522	Overweight	$38.50→ $38.00-1.3%
Aug 13 00:18 UTC	AMCX AMC Networks	◎ Target	UBS Group	John Hodulik ★★☆☆☆ #2386	Sell	$6.00→ $10.00+66.7%
Aug 13 00:18 UTC	AMBQ Ambiq Micro	◎ Target	Needham & Company LLC	N. Quinn Bolton not yet tracked	Buy	$70.00→ $85.00+21.4%
Aug 13 00:18 UTC	AMBQ Ambiq Micro	◎ Target	UBS Group	Timothy Arcuri ★★★☆☆ #1965	Neutral	$70.00→ $73.00+4.3%
Aug 13 00:18 UTC	ALS Altius Minerals	◎ Target	National Bank Financial	firm only	Outperform	C$70.00→ C$75.00+7.1%
Aug 13 00:18 UTC	AII American Integrity Insurance Group	◎ Target	Citizens Jmp	Matthew J. Carletti not yet tracked	Market Outperform	$25.00→ $26.00+4.0%
Aug 13 00:18 UTC	AIG American International Group	◎ Target	Morgan Stanley	Michael Phillips not yet tracked	Equal Weight	$82.00→ $81.00-1.2%
Aug 13 00:18 UTC	AFRM Affirm	◎ Target	BMO Capital Markets	Rufus Hone not yet tracked	Outperform	$78.00→ $86.00+10.3%
Aug 13 00:18 UTC	ADM Admiral Group	◎ Target	Royal Bank Of Canada	firm only	Sec→ r perform	GBX 3,450→ GBX 3,950+14.5%
Aug 13 00:18 UTC	ACM AECOM	◎ Target	Citigroup	Andrew Kaplowitz ★★★☆☆ #1130	Buy	$97.00→ $84.00-13.4%
Aug 13 00:18 UTC	ACM AECOM	◎ Target	Barclays	Adam Seiden ★★★☆☆ #1519	Equal Weight	$90.00→ $73.00-18.9%
Aug 13 00:18 UTC	ACM AECOM	◎ Target	KeyCorp	Sangita Jain ★★☆☆☆ #2732	Overweight	$101.00→ $79.00-21.8%
Aug 13 00:18 UTC	ACAD ACADIA Pharmaceuticals	◎ Target	Needham & Company LLC	Ami Fadia ★★★☆☆ #1953	Buy	$38.00→ $41.00+7.9%
Aug 13 00:18 UTC	AC Air Canada	◎ Target	BMO Capital Markets	firm only	Outperform	C$30.00→ C$37.00+23.3%
Aug 13 00:18 UTC	A Agilent Technologies	◎ Target	Morgan Stanley	Kallum Titchmarsh ★★★★★ #61	Overweight	$160.00→ $175.00+9.4%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!